Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients

Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Nephrol Renovasc Dis
Egile Nagusiak: Koike, Kiyomi, Fukami, Kei, Kawaguchi, Atsushi, Shimamatsu, Kazumasa, Yamagishi, Sho-ichi, Okuda, Seiya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822794/
https://ncbi.nlm.nih.gov/pubmed/27099526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S98196
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak